Schizophrenia Research
Volume 98, Issue 1 , Pages 118-128 , January 2008

Schizophrenia and sex associated differences in the expression of neuronal and oligodendrocyte-specific genes in individual thalamic nuclei

  • William Byne

      Affiliations

    • Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY, United States
    • Bronx Veterans Affairs Medical Center, 130 West Kingsbridge Road, Bronx, NY, United States
    • ,
  • Stella Dracheva

      Affiliations

    • Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY, United States
    • Bronx Veterans Affairs Medical Center, 130 West Kingsbridge Road, Bronx, NY, United States
    • ,
  • Benjamin Chin

      Affiliations

    • Bronx Veterans Affairs Medical Center, 130 West Kingsbridge Road, Bronx, NY, United States
    • ,
  • James M. Schmeidler

      Affiliations

    • Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY, United States
    • ,
  • Kenneth L. Davis

      Affiliations

    • Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY, United States
    • ,
  • Vahram Haroutunian

      Affiliations

    • Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY, United States
    • Bronx Veterans Affairs Medical Center, 130 West Kingsbridge Road, Bronx, NY, United States
    • Corresponding Author InformationCorresponding author. Psychiatry Research (3F-02), Bronx VA Medical Center, 130 West Kingsbridge Road, Bronx, 10468, NY, United States. Tel.: +1 718 584 9000x6082; fax: +1 718 365 9622.

Received 7 June 2007 ,Revised 18 September 2007 ,Accepted 24 September 2007.

References 

  1. Akbarian S, Huang HS. Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brains Res. Rev. 2006;52:293–304
  2. Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 2001;81:871–927
  3. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry. 1991;48:996–1001
  4. Bleier R. Retrograde transsynaptic cellular degeneration in mammillary and ventral tegmental nuclei following limbic decortication in rabbits of various ages. Brain Res. 1969;15:365–393
  5. Bruneau EG, McCullumsmith RE, Haroutunian V, Davis KL, Meador-Woodruff JH. Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia. Schizophr. Res. 2005;75:27–34
  6. Buchsbaum M, Someya T, Teng C, Abel L, Chin S, Najafi A, et al. PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am. J. Psychiatr. 1996;153:191–199
  7. Byne W, Stamu C, White L, Parrella M, Harvey PD, Davis KL. Prevalence and correlates of parkinsonism in an institutionalized population of geriatric patients with chronic schizophrenia. Int. J. Geriatr. Psychiatry. 2000;15:7–13
  8. Byne W, Buchsbaum MS, Kemether E, Hazlett EA, Shinwari A, Mitropoulou V, et al. Magnetic resonance imaging of the thalamic mediodorsal nucleus and pulvinar in schizophrenia and schizotypal personality disorder. Arch. Gen. Psychiatry. 2001;58:133–140
  9. Byne W, Tatusov A, Kidkarndee S, Yiannoulos G, Haroutunian V. Schizophrenia-associated reduction of oligodendrocytes in anterior thalamic nucleus. Schizophr. Res. 2006;85:245–253
  10. Cerghet M, Skoff RP, Bessert D, Zhang Z, Mullins C, Ghandour MS. Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodents. J. Neurosci. 2006;26:1439–1447
  11. Chance SA, Walker M, Crow TJ. Reduced density of calbindin-immunoreactive interneurons in the planum temporale in schizophrenia. Brain Res. 2005;1046:32–37
  12. Clinton SM, Haroutunian V, Meador-Woodruff JH. Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia. J. Neurochem. 2006;98:1114–1125(6 Jun)
  13. Cohen BM, Cherkerzian S, Ma J, Ye N, Wager C, Lange N. Cells in midline thalamus, central amygdala, and nucleus accumbens responding specifically to antipsychotic drugs. Psychopharmacology (Berl). 2003;167:403–410
  14. Cullen TJ, Walker MA, Parkinson N, Craven R, Crow TJ, Esiri MM, et al. A postmortem study of the mediodorsal nucleus of the thalamus in schizophrenia. Schizophr. Res. 2003;60:157–166
  15. Danos P, Baumann B, Bernstein HG, Franz M, Stauch R, Northoff G, et al. Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons. Psychiatry Res. 1998;82:1–10
  16. Danos P, Baumann B, Bernstein HG, Stauch R, Krell D, Falkai P, et al. The ventral lateral posterior nucleus of the thalamus in schizophrenia: a post-mortem study. Psychiatry Res. 2002;114:1–9
  17. Danos P, Baumann B, Kramer A, Bernstein HG, Stauch R, Krell D, et al. Volumes of association thalamic nuclei in schizophrenia: a postmortem study. Schizophr. Res. 2003;60:141–155
  18. Dewulf A. In: Anatomy of the Normal Human Thalamus. Amsterdam: Elsevier; 1971;
  19. Dorph-Petersen KA, Pierri JN, Sun Z, Sampson AR, Lewis DA. Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: volume, neuron number, and cell types. J. Comp. Neurol. 2004;472:449–462
  20. Dracheva S, Elhakem SL, McGurk SR, Davis KL, Haroutunian V. GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. J. Neurosci. Res. 2004;76:581–592
  21. Dracheva S, McGurk SR, Haroutunian V. mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics. J. Neurosci. Res. 2005;79:868–878
  22. Dracheva S, Davis KL, Chin B, Woo DA, Schmeidler J, Haroutunian V. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in schizophrenia. Neurobiol. Dis. 2006;79:157–173
  23. Eastwood SL, Harrison PJ. Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Schizophr. Res. 2005;73:159–172
  24. Fremeau RT, Voglmaier S, Seal RP, Edwards RH. VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci. 2004;27:98–103
  25. Gilbert AR, Rosenberg DR, Harenski K, Spencer S, Sweeney JA, Keshavan MS. Thalamic volumes in patients with first-episode schizophrenia. Am. J. Psychiatr. 2001;158:618–624
  26. Goldman-Rakic PS, Porrino LJ. The primate mediodorsal nucleus and its projections to the frontal lobe. J. Comp. Neurol. 1985;242:535–560
  27. Gur RE, Cowell PE, Latshaw A, Turetsky BI, Grossman RI, Arnold SE, et al. Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia. Arch. Gen. Psychiatry. 2000;57:761–768
  28. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2001;98:4746–4751
  29. Haroutunian V, Katsel P, Dracheva S, Davis KL. The human homolog of QKI gene affected in the severe dysmyelination “Quaking” mouse phenotype is downregulated in multiple brain regions in schizophrenia. Am. J. Psychiatr. 2006;163:1834–1837
  30. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J. Neurosci. 2003;23:6315–6326
  31. Hazlett EA, Buchsbaum MS, Kemether E, Bloom R, Platholi J, Brickman AM, et al. Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia. Am. J. Psychiatr. 2004;161:305–314
  32. Haznedar MM, Buchsbaum MS, Hazlett EA, Shihabuddin L, New A, Siever LJ. Cingulate gyrus volume and metabolism in the schizophrenia spectrum. Schizophr. Res. 2004;71:249–262
  33. Heckers S, Curran T, Goff D, Rauch SL, Fischman AJ, Alpert NM, et al. Abnormalities in the thalamus and prefrontal cortex during episodic object recognition in schizophrenia. Biol. Psychiatry. 2000;48:651–657
  34. Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes FM. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch. Gen. Psychiatry. 2002;59:521–529
  35. Heizmann CW. Calcium-binding proteins: basic concepts and clinical implications. Gen. Physiol. Biophys. 1992;11:411–425
  36. Highley JR, Walker MA, Crow TJ, Esiri MM, Harrison PJ. Low medial and lateral right pulvinar volumes in schizophrenia: a postmortem study. Am. J. Psychiatr. 2003;160:1177–1179
  37. Huerta I, McCullumsmith RE, Haroutunian V, Gimenez-Amaya JM, Meador-Woodruff JH. Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia. Synapse. 2006;59:394–402
  38. Jones EG. A new view of specific and nonspecific thalamocortical connections. Adv. Neurol. 1998;77:49–71(discussion 72-3., 49–71)
  39. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology. 2002;58:143–146
  40. Kemether EM, Buchsbaum MS, Byne W, Hazlett EA, Haznedar M, Brickman AM, et al. Magnetic resonance imaging of mediodorsal, pulvinar, and centromedian nuclei of the thalamus in patients with schizophrenia. Arch. Gen. Psychiatry. 2003;60:983–991
  41. Lehrer DS, Christian BT, Mantil J, Murray A, Buchsbaum BR, Oakes TR, et al. Thalamic and prefrontal FDG uptake in never-medicated patients with schizophrenia. Am. J. Psychiatr. 2005;162:931–938
  42. Lewis DA, Cruz DA, Melchitzky DS, Pierri JN. Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. Am. J. Psychiatr. 2001;158:1411–1422
  43. Lidow MS. Calcium signaling dysfunction in schizophrenia: a unifying approach. Brain Res. Brain Res. Rev. 2003;43:70–84
  44. McLardy T. Thalamic attention circuitry normal and psychotic. Med. Hypotheses. 1984;15:231–239
  45. Munkle MC, Waldvogel HJ, Faull RL. The distribution of calbindin, calretinin and parvalbumin immunoreactivity in the human thalamus. J. Chem. Neuroanat. 2000;19:155–173
  46. Myers JL. In: Fundamentals of Experimental Design. vol. 2:Boston: Allyn and Bacon; 1972;
  47. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch. Gen. Psychiatry. 1990;47:1023–1028
  48. Pakkenberg B. The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics. Schizophr. Res. 1992;7:95–100
  49. Pakkenberg B, Gundersen H. Total number of neurons and glial cells in human brain nuclei estimatd by the disector and the fractionator. J. Microsc. 1988;150:1–20
  50. Popken GJ, Bunney WE, Potkin SG, Jones EG. Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc. Natl. Acad. Sci. U. S. A. 2000;97:9276–9280
  51. Purohit DP, Perl DP, Haroutunian V, Powchik P, Davidson M, Davis KL. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Arch. Gen. Psychiatry. 1998;55:205–211
  52. Seeman MV. Women and schizophrenia. Medscape Womens Health. 2000;5:2
  53. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry. 1995;52:805–818
  54. Selemon LD, Rajkowska G, Goldman-Rakic PS. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J. Comp. Neurol. 1998;392:402–412
  55. Smith RE, Haroutunian V, Davis KL, Meador-Woodruff JH. Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. Am. J. Psychiatr. 2001;158:1393–1399
  56. Spreafico R, Schmechel DE, Ellis LC, Rustioni A. Cortical relay neurons and interneurons in the N. ventralis posterolateralis of cats: a horseradish peroxidase, electron-microscopic, Golgi and immunocytochemical study. Neuroscience. 1983;9:491–509
  57. Stark AK, Uylings HB, Sanz-Arigita E, Pakkenberg B. Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am. J. Psychiatr. 2004;161:882–888
  58. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 2003;362:798–805
  59. Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol. Psychiatry. 2005;57:252–260
  60. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:(RESEARCH0034)
  61. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen. Psychiatry. 2000;57:237–245
  62. Voskuhl RR. Gender issues and multiple sclerosis. Curr. Neurol. Neurosci. Rep. 2002;2:277–286
  63. Young KA, Holcomb LA, Yazdani U, Hicks PB, German DC. Elevated neuron number in the limbic thalamus in major depression. Am. J. Psychiatry. 2004;161:1270–1277
  64. Young KA, Manaye KF, Liang C, Hicks PB, German DC. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol. Psychiatry. 2000;47:944–953

☆ This study is supported by MH064673 (VH), MH066392 (KLD), Veterans Administration MIRECC and Merit Reviews (VH, SD, and WB).

PII: S0920-9964(07)00436-7

doi: 10.1016/j.schres.2007.09.034

Schizophrenia Research
Volume 98, Issue 1 , Pages 118-128 , January 2008

Article Tools

* Image Usage & Resolution